A 35-year-old man with a history of intravenous drug use presents with a 2-week history of fever, malaise, and new cardiac murmur (holosystolic murmur at the left lower sternal border). Echocardiography reveals a 1.2 cm vegetation on the tricuspid valve with moderate tricuspid regurgitation. Blood cultures (3 sets) grow Gram-positive cocci in clusters, catalase-positive, coagulase-positive, resistant to oxacillin. What is the most appropriate initial antibiotic regimen?
A. Ceftriaxone 2 g IV Q12H + gentamicin 3 mg/kg IV Q8H
B. Clindamycin 600 mg IV Q6H monotherapy
C. Vancomycin 15–20 mg/kg IV Q8–12H + gentamicin 3 mg/kg IV Q8H
D. Nafcillin 2 g IV Q4H + gentamicin 3 mg/kg IV Q8H
Explanation
Clinical Diagnosis
Key Point
Right-sided endocarditis (tricuspid valve involvement) in an IVDU with MRSA bacteremia is a classic presentation. The organism is identified as Gram-positive, catalase-positive, coagulase-positive, and oxacillin-resistant = MRSA.
Organism Confirmation
Table
Test
Result
Interpretation
Gram stain
Cocci in clusters
Staphylococcus sp.
Catalase
Positive
Not Streptococcus
Coagulase
Positive
S. aureus (not S. epidermidis)
Oxacillin resistance
Resistant
MRSA (mecA gene present)
High-YieldNEET PG
MRSA is the leading cause of infective endocarditis in IVDUs in developed countries and increasingly in India. Right-sided (tricuspid) involvement is typical in IVDU endocarditis.
Treatment of MRSA Endocarditis
Clinical Pearl
Vancomycin monotherapy is inadequate for S. aureus endocarditis. Combination therapy with an aminoglycoside is required for synergy and improved bactericidal activity, especially in the setting of prosthetic valves or complex disease.
Recommended Regimen for Native Valve MRSA Endocarditis
1.
Vancomycin 15–20 mg/kg IV Q8–12H
Target trough: 15–20 μg/mL (higher targets for CNS involvement)
Renal function monitoring essential
2.
Gentamicin 3 mg/kg IV Q8H (first 2 weeks minimum)
Provides synergy against S. aureus
Improves valve sterilization and reduces embolic complications
Prosthetic valve: 6 weeks of vancomycin + gentamicin (first 2 weeks), followed by 4 weeks of vancomycin monotherapy
Mnemonic
VG-MRSA = Vancomycin + Gentamicin for MRSA endocarditis.
Why This Answer
MRSA endocarditis requires dual therapy for optimal outcomes. Vancomycin penetrates vegetations and provides reliable MRSA coverage; gentamicin adds synergy and improves bacterial killing. This combination is guideline-recommended for both native and prosthetic valve disease.
Practice similar questions
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.
